Literature DB >> 1108702

Delta-9-tetrahydrocannabinol and lysergic acid diethylamide: comparative changes in the supraoptic and paraventricular neurosecretory activities in rat hypothalamus.

B Biswas, J J Ghosh.   

Abstract

Acute delta-9-tetrahydrocannabinol (Delta-9-THC) administration (50 mg/kg, i.p.) produced accumulation of stainable neurosecretory materials (NSM) in the neural lobe (NL) region with a concomitant dispersion of stainable NSM in the neuronal perikarya of hypothalamic supraoptic nucleus (SON) and paraventricular nucleus (PVN) regions. Chronic treatment with delta-9-THC (10 mg/kg, 15 days) produced marked accumulation of NSM in the NL with more prominent degranulation of the neuronal perikarya of SON and PVN. Acute LSD treatment (50 mug/kg) caused accumulation of stainable NSM in the NL region, with unaltered perikaryal distribution pattern of both SON and PVN; chronic LSD treatment (10 mug/kg, 15 days), on the other hand, caused marked increase of NSM in the neuronal perikarya of SON and PVN with no prominent accumulation in the NL. Results indicated that chronic exposure of delta-9-THC lowered the functional activity of SON and PVN neurons while chronic LSD treatment stimulated the hypothalamo-neurohypophyseal neurosecretory system of rats.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1108702

Source DB:  PubMed          Journal:  Anat Anz        ISSN: 0003-2786


  2 in total

1.  Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain.

Authors:  Michiru Hirasawa; Yannick Schwab; Sirajedin Natah; Cecilia J Hillard; Ken Mackie; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2004-07-14       Impact factor: 5.182

Review 2.  Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics.

Authors:  Emmanuelle A D Schindler; Ryan M Wallace; Jordan A Sloshower; Deepak C D'Souza
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.